Jeremy Sugarman

18.8k total citations
406 papers, 9.9k citations indexed

About

Jeremy Sugarman is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Physiology. According to data from OpenAlex, Jeremy Sugarman has authored 406 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 219 papers in Public Health, Environmental and Occupational Health, 128 papers in General Health Professions and 70 papers in Physiology. Recurrent topics in Jeremy Sugarman's work include Ethics in Clinical Research (154 papers), Ethics in medical practice (79 papers) and Biomedical Ethics and Regulation (68 papers). Jeremy Sugarman is often cited by papers focused on Ethics in Clinical Research (154 papers), Ethics in medical practice (79 papers) and Biomedical Ethics and Regulation (68 papers). Jeremy Sugarman collaborates with scholars based in United States, United Kingdom and Canada. Jeremy Sugarman's co-authors include Ruth Faden, Robert M. Califf, John A. Crump, Nancy Kass, Neal W. Dickert, Douglas C McCrory, Ruth W. Grant, Kevin P. Weinfurt, Jason Karlawish and Christopher K. Glass and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jeremy Sugarman

396 papers receiving 9.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Sugarman United States 50 4.6k 3.0k 1.3k 1.2k 960 406 9.9k
Robert A. Hiatt United States 64 2.3k 0.5× 2.1k 0.7× 764 0.6× 1.2k 1.0× 538 0.6× 245 14.1k
Michael J Goldacre United Kingdom 63 2.8k 0.6× 2.6k 0.9× 715 0.5× 830 0.7× 850 0.9× 371 14.7k
Electra D. Paskett United States 62 3.0k 0.7× 2.8k 0.9× 1.5k 1.1× 773 0.6× 1.3k 1.3× 476 15.5k
Susan J. Curry United States 79 4.5k 1.0× 3.8k 1.3× 5.1k 3.8× 1.0k 0.8× 946 1.0× 221 19.4k
Melissa A. Simon United States 63 3.2k 0.7× 3.6k 1.2× 999 0.8× 668 0.5× 636 0.7× 351 16.6k
Myfanwy Morgan United Kingdom 53 2.4k 0.5× 3.4k 1.1× 667 0.5× 284 0.2× 1.3k 1.4× 243 12.8k
Chirayath Suchindran United States 53 1.5k 0.3× 2.2k 0.7× 811 0.6× 573 0.5× 381 0.4× 173 10.4k
Jae Il Shin South Korea 49 1.3k 0.3× 1.4k 0.5× 1.5k 1.1× 1.6k 1.3× 395 0.4× 547 14.8k
William Rosenberg United Kingdom 52 3.5k 0.8× 5.6k 1.9× 668 0.5× 1.2k 1.0× 1.4k 1.5× 260 22.4k
David Goldstein Australia 64 1.9k 0.4× 1.5k 0.5× 882 0.7× 2.7k 2.2× 392 0.4× 446 18.7k

Countries citing papers authored by Jeremy Sugarman

Since Specialization
Citations

This map shows the geographic impact of Jeremy Sugarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Sugarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Sugarman more than expected).

Fields of papers citing papers by Jeremy Sugarman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Sugarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Sugarman. The network helps show where Jeremy Sugarman may publish in the future.

Co-authorship network of co-authors of Jeremy Sugarman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Sugarman. A scholar is included among the top collaborators of Jeremy Sugarman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Sugarman. Jeremy Sugarman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonlin, Erica C., Misao Fujita, Rosario Isasi, et al.. (2025). What does “appropriate scientific justification” mean for the review of human pluripotent stem cell, embryo, and related research?. Stem Cell Reports. 20(5). 102479–102479. 1 indexed citations
2.
Nguyen, Elizabeth, Ali Ahmed, Steven Meanley, et al.. (2025). Participant Perspectives in an HIV Treatment Interruption Study in San Francisco, United States. AIDS Research and Human Retroviruses. 41(11). 505–516. 1 indexed citations
3.
Meyer, Michelle N., Nicholas Papageorge, Erik Parens, et al.. (2024). Potential corporate uses of polygenic indexes: Starting a conversation about the associated ethics and policy issues. The American Journal of Human Genetics. 111(5). 833–840. 1 indexed citations
4.
Kim, Ellie, Sarah E. Van Pilsum Rasmussen, Morgan Johnson, et al.. (2024). Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia. Open Forum Infectious Diseases. 11(3). 1 indexed citations
5.
Tackett, Sean, Chirk Jenn Ng, Jeremy Sugarman, et al.. (2023). A Competency Framework for Health Research Ethics Educational Programs: Results from a Stakeholder‐Driven Mixed‐Method Process. PubMed. 45(3). 29–39. 2 indexed citations
6.
Draelos, Zoé Kececioglu, Emil Tanghetti, Leon Kircik, et al.. (2023). Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials. Journal of Dermatological Treatment. 34(1). 2220446–2220446. 1 indexed citations
7.
Tackett, Sean, Chirk Jenn Ng, Jeremy Sugarman, et al.. (2023). Defining Malaysia's health research ethics system through a stakeholder driven approach. Developing World Bioethics. 24(2). 74–83. 1 indexed citations
8.
Morain, Stephanie R., Juli Bollinger, Kevin P. Weinfurt, & Jeremy Sugarman. (2023). Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements. Learning Health Systems. 8(1). e10366–e10366. 3 indexed citations
10.
Sugarman, Jeremy, Nanette B. Silverberg, Mercedes E. González, et al.. (2021). Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children. Pediatric Dermatology. 38(6). 1500–1505. 21 indexed citations
11.
Meyer, Michelle N., Luke Gelinas, Barbara E. Bierer, et al.. (2021). An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials. 18(2). 226–233. 15 indexed citations
12.
Diepstra, Karen, Elizabeth Barr, David Palm, et al.. (2021). Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study. AIDS Research and Human Retroviruses. 37(6). 489–501. 8 indexed citations
13.
Sun, Qisi, et al.. (2020). Clues to primary vismodegib resistance lie in histology and genetics. Journal of Clinical Pathology. 73(10). 678–680. 7 indexed citations
14.
Eichenfield, Lawrence F., Jeremy Sugarman, Eric Guenin, Susan Harris, & Varsha Bhatt. (2019). Novel tretinoin 0.05% lotion for the once‐daily treatment of moderate‐to‐severe acne vulgaris in a preadolescent population. Pediatric Dermatology. 36(2). 193–199. 12 indexed citations
15.
Durand, Christine M., Mary G. Bowring, Diane Brown, et al.. (2018). Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients. Annals of Internal Medicine. 2 indexed citations
16.
Skinner, Celette Sugg, Joellen M. Schildkraut, Donald A. Berry, et al.. (2002). Pre-Counseling Education Materials for BRCA Testing: Does Tailoring Make a Difference?. Genetic Testing. 6(2). 93–105. 58 indexed citations
17.
Sugarman, Jeremy & Philip M. Rosoff. (2001). Ethical Issues in Gamete Preservation for Children Undergoing Treatment for Cancer. Journal of Andrology. 22(5). 732–737. 2 indexed citations
18.
Sugarman, Jeremy. (2000). Ethics in primary care. DigitalGeorgetown (Georgetown University Library). 13 indexed citations
19.
Sugarman, Jeremy, et al.. (1999). Empirical Research on Informed Consent. The Hastings Center Report. 29(1). 42 indexed citations
20.
Klingman, David, et al.. (1996). Measuring Defensive Medicine Using Clinical Scenario Surveys. Journal of Health Politics Policy and Law. 21(2). 185–220. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026